Medikabazaar faces Rs 279 Cr indemnity claim as investors allege financial misstatements

Medikabazaar is facing a substantial ₹279 crore indemnity claim from its investors, who allege financial misstatements by the company. This development follows the recent ousting of the former CEO over fraud allegations, further compounding the challenges faced by the B2B medical supply marketplace. The investors' claim suggests a serious breach of trust and potential misrepresentation of the company's financial health during due diligence or fundraising processes. This legal battle could have significant financial and reputational consequences for Medikabazaar and may impact investor confidence in the broader healthtech startup ecosystem. The outcome of this claim will be closely monitored.